Skip to main content

Animations

MJFF Publications

7331 - 7340 of 9038 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2018
  • 2018
  • 2016
  • 2018
  • 2019
  • 2018
  • Summary Details
    OPEN
    Title: Parkinson's disease: Still waiting for a cure
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/cts.13898
    Citation Count: 1
  • Dual-task gait has prognostic value for cognitive decline in Parkinson’s disease
    2024
    Summary Details
    RESTRICTED
    Title: Dual-task gait has prognostic value for cognitive decline in Parkinson’s disease
    Journal Name: Journal of Clinical Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jocn.2024.06.006
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.99914.3
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A genetic and proteomic comparison of key AD biomarkers across tissues
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.14139
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Effect of rs3910105 in the Synuclein Gene on Dopamine Transporter Availability in Healthy Subjects
    Journal Name: Yonsei Medical Journal
    Publisher: XMLink
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3349/ymj.2018.59.6.787
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure
    Journal Name: Frontiers in Endocrinology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fendo.2018.00608
    Citation Count: 20
  • Summary Details
    OPEN
    Title: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2016.00174
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2018.00560
    Citation Count: 57
  • Summary Details
    OPEN
    Title: White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime Sleepiness
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2019.00378
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2018.00230
    Citation Count: 28
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.